Full Text View
Tabular View
No Study Results Posted
Related Studies
Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea
This study is currently recruiting participants.
Study NCT00669929   Information provided by Yonsei University
First Received: April 29, 2008   Last Updated: February 18, 2009   History of Changes

April 29, 2008
February 18, 2009
May 2008
June 2009   (final data collection date for primary outcome measure)
patients' cost [ Time Frame: one year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00669929 on ClinicalTrials.gov Archive Site
 
 
 
Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea
Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea

The primary objective of the proposed project is to estimate the economic impact of a national rotavirus immunization program in preventing rotavirus diarrhea among Korean children.

Rotavirus is the leading cause of severe acute diarrhea or gastroenteritis among young children worldwide. In the first 5 years of life, about 90% of children experience at least one episode of rotavirus infection.Each year, rotavirus diarrhea is responsible for 440,000 deaths, 2 million hospitalizations, and 25 million outpatient visits among children younger than 5 years worldwide. In South Korea, rotavirus diarrhea rarely causes mortality, but it cause significant morbidity. A recent population-based study in Korea has estimated that the annual incidence of rotavirus diarrhea accounts for 56.9 cases per 1,000 children less than 5 years old. Oral, live pentavalent human-bovine reassortant rotavirus vaccine has been developed and licensed for the use of preventing rotavirus disease in many countries. Yet, there has been no research done to assess the impact of national rotavirus immunization program in Korea. It is expected that systematic appraisal on the national burden of rotavirus infection and potential public health and economic benefits of rotavirus vaccination for children in Korea will assists health policy makers to set a priority for the prevention of this disease.

 
Observational
Cohort, Retrospective
  • Gastroenteritis
  • Rotavirus Vaccines
  • Cost-Effectiveness
 
  • patients visited to Severance hospital
  • patients visited to Youngdong Severance hospital
  • patients visited to Wonju Christian hospital

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
200
June 2009
June 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • children aged under 5 years and diagnosed as acute gastroenteritis

Exclusion Criteria:

  • none
Both
up to 5 Years
No
Contact: Dong Soo Kim, MD, PhD 82-2-2228-2005 dskim6634@yuhs.ac
Contact: Ki Hwan Kim, MD 82-2-2227-4188 khkim99@yuhs.ac
Korea, Republic of
 
NCT00669929
Yonsei University Health System Severance Hospital, Yonsei University
rota-001, yonsei-rota
Yonsei University
  • Merck
  • Severance Hospital
Principal Investigator: Dong Soo Kim, MD, PhD professor
Yonsei University
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP